期刊文献+

蛋白质组学研究在炎症性肠病中的应用

The application of proteomics in inflammatory bowel disease
下载PDF
导出
摘要 目前临床上暂无得到公认的且广泛开展的炎症性肠病生物学标志物,利用蛋白质组学技术寻找疾病临床标志物在肿瘤性疾病中的应用一直是研究热点,然而在炎症性疾病中应用的研究尚少。本文对近年来国内外利用蛋白质组学寻找炎症性肠病诊断及鉴别诊断、病情评估、治疗疗效预测以及癌变风险监测的生物学标志物研究进行概述。 At present, there are no widely recognized and used biomarkers for inflammatory bowel disease. The use of proteomic methods to find clinical markers has always been a hot spot in oncological diseases, however, the application of proteomic methods in inflammatory diseases is still rare. In this article, we summarized recent proteomic research to find biomarkers in diagnosis and differential diagnosis, activity assessment, therapeutic efficacy prediction and cancer risk monitoring of inflammatory bowel disease.
作者 孙颖昊 李骥 钱家鸣 SUN Yinghao;LI Ji;QIAN Jiaming(Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China)
出处 《胃肠病学和肝病学杂志》 CAS 2019年第8期841-843,共3页 Chinese Journal of Gastroenterology and Hepatology
基金 卫生行业科研专项基金项目(201002020)
关键词 炎症性肠病 蛋白质组学 标志物 Inflammatory bowel disease Proteomics Biomarker
  • 相关文献

参考文献3

二级参考文献180

  • 1陈隆典,孙凌云.脉冲式小剂量环磷酰胺治疗难治性炎症性肠病[J].中华消化杂志,2005,25(9):561-562. 被引量:2
  • 2Maria Papp,Gary L Norman,Istvan Altorjay,Peter Laszlo Lakatos.Utility of serological markers in inflammatory bowel diseases: Gadget or magic?[J].World Journal of Gastroenterology,2007,13(14):2028-2036. 被引量:24
  • 3中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1018
  • 4J.L. Mendoza,M.T. Abreu.Biological markers in inflammatory bowel disease: Practical consideration for clinicians[J]. Gastroenterologie Clinique et Biologique . 2009
  • 5Marie-Alice Meuwis,Marianne Fillet,Pierre Geurts,Dominique de Seny,Laurence Lutteri,Jean-Paul Chapelle,Vincent Bours,Louis Wehenkel,Jacques Belaiche,Michel Malaise,Edouard Louis,Marie-Paule Merville.Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling[J]. Biochemical Pharmacology . 2007 (9)
  • 6Natasha S. Stephens,Jesse Siffledeen,Xiaorong Su,Travis B. Murdoch,Richard N. Fedorak,Carolyn M. Slupsky.Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy[J].Journal of Crohn’s and Colitis.2012
  • 7Horace Williams,James Willsmore,I. Cox,David Walker,Jeremy Cobbold,Simon Taylor-Robinson,Timothy Orchard.Serum Metabolic Profiling in Inflammatory Bowel Disease[J].Digestive Diseases and Sciences.2012(8)
  • 8Axel Dignass,Rami Eliakim,Fernando Magro,Christian Maaser,Yehuda Chowers,Karel Geboes,Gerassimos Mantzaris,Walter Reinisch,Jean-Frederic Colombel,Severine Vermeire,Simon Travis,James O. Lindsay,Gert Van Assche.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis[J].Journal of Crohn’s and Colitis.2012(10)
  • 9Gert Van Assche,Axel Dignass,Julian Panes,Laurent Beaugerie,John Karagiannis,Mathieu Allez,Thomas Ochsenkühn,Tim Orchard,Gerhard Rogler,Edouard Louis,Limas Kupcinskas,Gerassimos Mantzaris,Simon Travis,Eduard Stange.The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis[J].Journal of Crohn’s and Colitis.2009(1)
  • 10Adam M Zahm,Meena Thayu,Nicholas J Hand,Amber Horner,Mary B Leonard,Joshua R Friedman.Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease[J].Journal of Pediatric Gastroenterology and Nutrition.2011(1)

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部